Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$341,645,679
-$115,310,301 QoQ
Shares Held
8,008,572
-15.6% QoQ
Ownership
0.334%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#4
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 37%
Shared 0%
None 63%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $41,356,581,132 across 16 Drug Manufacturers - General names. SNY ranks #12 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,274,243 | $13,522,666,405 | |
| 2 | JNJ |
Johnson & Johnson
|
23,438,141 | $5,952,584,668 | |
| 3 | ABBV |
AbbVie Inc.
|
21,237,764 | $5,344,270,929 | |
| 4 | MRK |
Merck & Co., Inc.
|
30,535,208 | $3,923,774,226 | |
| 5 | AZN |
Astrazeneca PLC
|
17,690,462 | $3,354,465,400 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
18,649,065 | $2,356,122,869 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
34,045,352 | $1,961,693,176 | |
| 8 | AMGN |
Amgen Inc
|
5,058,830 | $1,831,903,515 |
All Filings in SNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $341,645,679 | 8,008,572 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $456,955,980 | 9,484,350 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $414,042,623 | 8,544,008 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $465,980,816 | 9,872,475 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $483,028,932 | 9,998,529 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $577,216,030 | 10,407,790 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $579,586,658 | 12,017,140 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $667,096,235 | 11,575,503 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $543,818,804 | 11,208,137 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $536,651,452 | 11,042,211 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $506,875,956 | 10,192,559 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $567,725,220 | 10,583,990 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $562,763,967 | 10,440,890 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $578,318,016 | 10,626,939 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $439,991,729 | 9,085,107 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $415,538,598 | 10,929,474 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $676,388,837 | 13,519,665 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $618,745,622 | 12,051,921 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $528,028,296 | 10,539,487 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $493,374,388 | 10,233,860 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $522,642,071 | 9,924,840 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $449,647,731 | 9,091,139 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $414,005,310 | 8,520,381 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $429,046,059 | 8,551,845 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $484,189,336 | 9,484,610 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $448,979,345 | 10,269,427 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||